Details for New Drug Application (NDA): 205968
✉ Email this page to a colleague
The generic ingredient in LEVOFLOXACIN is levofloxacin. There are thirty-one drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.
Summary for 205968
| Tradename: | LEVOFLOXACIN |
| Applicant: | Zydus Pharms |
| Ingredient: | levofloxacin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205968
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG/20ML (EQ 25MG/ML) | ||||
| Approval Date: | Jun 1, 2017 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 750MG/30ML (EQ 25MG/ML) | ||||
| Approval Date: | Jun 1, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
